Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06300658Recruiting
Randomised, open-label trial of lidocaine in arteriovenous fistula dysfunction (2 arms), sponsored by Aswan University. Primary endpoint: Fistula flow rate. Started Mar 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06300658.